Cargando…
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
BACKGROUND: The use of molecular biomarkers for COVID-19 remains unconclusive. The application of a molecular biomarker in combination with clinical ones that could help classifying aggressive patients in first steps of the disease could help clinician and sanitary system a better management of the...
Autores principales: | Martinez-Diz, Silvia, Morales-Álvarez, Carmen Maria, Garcia-Iglesias, Yarmila, Guerrero-González, Juan Miguel, Romero-Cachinero, Catalina, González-Cabezuelo, Jose María, Fernandez-Rosado, Francisco Javier, Arenas-Rodríguez, Verónica, Lopez-Cintas, Rocío, Alvarez-Cubero, Maria Jesús, Martinez-Gonzalez, Luis Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245351/ https://www.ncbi.nlm.nih.gov/pubmed/37287057 http://dx.doi.org/10.1186/s40246-023-00496-2 |
Ejemplares similares
-
Sex, androgens and regulation of pulmonary AR, TMPRSS2 and ACE2
por: Baratchian, Mehdi, et al.
Publicado: (2020) -
Determination of Exosome Mitochondrial DNA as a Biomarker of Renal Cancer Aggressiveness
por: Arance, Elena, et al.
Publicado: (2021) -
Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19
por: Martínez-Diz, Silvia, et al.
Publicado: (2023) -
Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate Cancer
por: Martínez-González, Luis Javier, et al.
Publicado: (2021) -
Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes
por: Baratchian, Mehdi, et al.
Publicado: (2021)